Category | Insight journal – Dealtalk

Actavis chasing Allergan also…which way will Allergan go?

Posted on 15 October 2014

Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.

Arbor Pharma looking for an acquisition and merger partner

Posted on 06 October 2014

Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.

Tags: , , ,

Pfizer is in talks to acquire Actavis

Posted on 24 September 2014

Pfizer Inc. has approached Actavis with a possibility to acquire the company.

Tags: , ,

Akorn to bid for an acquisition of UCB’s subsidiary

Posted on 15 September 2014

Akorn targets UCB’s subsidiary for acquisition for tax inversion. 

Tags: , ,

Omega Pharma rumored to be sought after by big pharma companies

Posted on 01 September 2014

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company. 

Tags: , , , , ,

AstraZeneca and Pfizer in the news for another possible m&a bid

Posted on 01 September 2014

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer.

Tags: , , ,

M&A rumors for buyout of Achillion Pharmaceuticals by big pharma

Posted on 28 August 2014

UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come.

Tags: , , ,

Roche drops business merger rumors with Chugai Pharmaceutical

Posted on 27 August 2014

Roche had business merger rumors to buy Tokyo-based Chugai Pharmaceutical Co., Ltd. appear to be tabled for now. Sources in Roche indicated the company was focused on its $8.3 billion acquisition of California-based InterMune Inc.

Tags: , , ,

Is Pfizer’s next acquisition target, Actavis?

Posted on 22 August 2014

Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets.

Tags: , ,

Mylan bids on old drugs of GSK

Posted on 22 August 2014

Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.  

Tags: , , , , ,